Eram Khan

• Kelonia Therapeutics on its acquisition by Eli Lilly for $7 billion
• Ouro Medicines on its sale to Gilead Sciences for up to $2.375 billion
• Orna Therapeutics, a biotechnology company, in connection with its acquisition by Eli Lilly for up to $2.4 billion
• Isomorphic Labs on its research collaboration with Johnson & Johnson, a strategic collaboration combining AI-driven drug discovery with global pharmaceutical development capabilities
• Vicebio, a biotech firm developing next-generation vaccines for respiratory viruses, on its $1.6 billion sale to Sanofi
• Teleflex Inc, a global provider of medical technologies, on the merger control and FDI aspects of its acquisition of the vascular intervention business of Biotronik SE & Co. KG
• Anthos Therapeutics on its acquisition by Novartis for up to $3.1 billion
• LumiThera, an ophthalmic medical device company, on the antitrust aspects of its acquisition by Alcon
• Eidos Therapeutics and BridgeBio International GmbH on their exclusive license agreement to develop and commercialize acoramidis as a treatment for transthyretin amyloidosis in Europe with Bayer Consumer Care AG
• Versanis Bio in connection with its acquisition by Eli Lilly for up to $1.925 billion
• Inversago Pharma on its $1.7 billion acquisition by Novo Nordisk
• Globus Medical, a leading musculoskeletal solutions company, on its definitive agreement to combine in an all-stock transaction with NuVasive
• TCR2 Therapeutics on its strategic combination with Adaptimmune Therapeutics to create a pre-eminent cell therapy company focused on treating solid tumors
• SunMed Group on its definitive agreement to acquire the respiratory health business of Avanos Medical, Inc.
• Novartis on the EU and global merger clearances for its transformational three-way, inter-conditional asset swap with GSK concerning oncology, vaccines and consumer health products (GCR Matter of the Year and FT Innovative Lawyers Award)*

*Denotes experience prior to joining Goodwin

• Isovalent Inc., a cloud native networking and security solutions provider, on its acquisition by Cisco Systems, Inc
• Envato, a leading online platform for creative assets and tools, on its agreement to sell its entire issued share capital to Shutterstock
• SevenRooms, a CRM, marketing, and operations platform for the hospitality industry, on its acquisition agreement with DoorDash
• Qualtrics International on its $12.5 billion sale to Silver Lake and CCP Investments
• TA Associates and Warburg Pincus on their investment in Epassi Group, a leading digital payments provider for employee benefits, from Bregal Milestone, and subsequent combination with the Exercite Group, a B2B fitness platform previously owned by Waterland

• The Telegraph Media Group and the independent directors on its Board in connection with the public interest review of its proposed acquisition by Redbird IMI
• Arlington Capital and its portfolio company BlueHalo on its $4.1 billion all-stock acquisition by AeroVironment
• Color Wow, one of the fastest-growing US/UK-based haircare brands, on its acquisition by L’Oréal
• Ferrara’s European holding company, part of the Ferrero group, on its acquisition of CPK Group, a leading French confectionery and chocolate company
• Lloyds Banking Group on the acquisition of Tesco Bank’s prime £3.7 billion UK residential mortgage portfolio and the acquisition of Zurich’s UK workplace pensions and savings business*
• Deutsche Börse on the European Commission’s in-depth investigation into its proposed £21 billion merger with the London Stock Exchange Group*
• Cerberus Capital Management on its acquisition of Worldwide Flight Services, one of the world’s leading providers of air cargo and ground handling services*

*Denotes experience prior to joining Goodwin

• Glencore on the multi-jurisdictional merger control clearances for its acquisition of its remaining stake in the Cerrejón coal mine in Colombia from its joint venture partners, Anglo American and BHP*
• Jingye Group, a Chinese steel company, on the merger control aspects of its acquisition of certain assets of British Steel*
• Glencore on various merger control and competition law compliance matters, including its $70 billion acquisition of the remaining stake in Xstrata and on their $775.2 million sale of a 51% stake in its global oil storage business to HNA*

*Denotes experience prior to joining Goodwin

• A consortium of banks led by JP Morgan and Standard Chartered on the antitrust considerations relating to the restructuring of their positions on the London Metal Exchange (LME), held on behalf of stainless steel producer Tsingshan Holdings Group following a short squeeze in the nickel market*
• JP Morgan Chase & Co on the competition law aspects of the UK’s Financial Conduct Authority market study into Investment and Corporate Banking*
• An automotive parts company as the immunity applicant in the European Commission’s investigation concerning various automotive components, forming part of what has been described as the “largest cartel investigation in history”*

*Denotes experience prior to joining Goodwin